Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA48242
Max Phase: Preclinical
Molecular Formula: C26H24N6O2
Molecular Weight: 452.52
Molecule Type: Small molecule
Associated Items:
ID: ALA48242
Max Phase: Preclinical
Molecular Formula: C26H24N6O2
Molecular Weight: 452.52
Molecule Type: Small molecule
Associated Items:
Synonyms (1): CV-11194
Synonyms from Alternative Forms(1):
Canonical SMILES: CCCCc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
Standard InChI: InChI=1S/C26H24N6O2/c1-2-3-11-23-27-22-10-6-9-21(26(33)34)24(22)32(23)16-17-12-14-18(15-13-17)19-7-4-5-8-20(19)25-28-30-31-29-25/h4-10,12-15H,2-3,11,16H2,1H3,(H,33,34)(H,28,29,30,31)
Standard InChI Key: FLOKGHWIQFCIJW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 452.52 | Molecular Weight (Monoisotopic): 452.1961 | AlogP: 4.97 | #Rotatable Bonds: 8 |
Polar Surface Area: 109.58 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.85 | CX Basic pKa: 5.86 | CX LogP: 4.45 | CX LogD: 1.85 |
Aromatic Rings: 5 | Heavy Atoms: 34 | QED Weighted: 0.34 | Np Likeness Score: -1.05 |
1. Kubo K, Inada Y, Kohara Y, Sugiura Y, Ojima M, Itoh K, Furukawa Y, Nishikawa K, Naka T.. (1993) Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles., 36 (12): [PMID:8510105] [10.1021/jm00064a011] |
2. Kubo K, Kohara Y, Imamiya E, Sugiura Y, Inada Y, Furukawa Y, Nishikawa K, Naka T.. (1993) Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids., 36 (15): [PMID:8340921] [10.1021/jm00067a016] |
3. Kubo K, Kohara Y, Yoshimura Y, Inada Y, Shibouta Y, Furukawa Y, Kato T, Nishikawa K, Naka T.. (1993) Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids., 36 (16): [PMID:8360879] [10.1021/jm00068a011] |
4. Kohara Y, Kubo K, Imamiya E, Wada T, Inada Y, Naka T.. (1996) Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosteres., 39 (26): [PMID:8978851] [10.1021/jm960547h] |
5. Naik P, Murumkar P, Giridhar R, Yadav MR.. (2010) Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective., 18 (24): [PMID:21071232] [10.1016/j.bmc.2010.10.043] |
6. Jain A, Chaturvedi SC. (2010) QSAR modeling of some substituted benzimidazole as Angotensin II AT1 receptor antagonist, 19 (2): [10.1007/s00044-009-9182-z] |
Source(1):